Edition:
United Kingdom

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

86.81USD
22 Jun 2018
Change (% chg)

$0.51 (+0.59%)
Prev Close
$86.30
Open
$86.66
Day's High
$87.57
Day's Low
$86.61
Volume
2,812,930
Avg. Vol
1,386,088
52-wk High
$89.71
52-wk Low
$76.42

Select another date:

Thu, May 24 2018

Medtronic beats estimates on cardio, diabetes gains

Medtronic Plc topped analysts' estimates for profit in the fourth quarter as it kept a tight lid on costs and upped sales of its heart valves and insulin pumps, offsetting the impact of hurricane damage to production in Puerto Rico.

UPDATE 3-Medtronic beats estimates on cardio, diabetes gains

* Shares up 3 percent (Adds details, analysts' comments, updates share price)

RPT-Medical device maker Medtronic reports 25.5 pct rise in profit

May 24 Medtronic Plc reported a 25.5 percent rise in quarterly profit on Thursday on higher demand for its heart devices.

Medical device maker Medtronic reports 25.5 pct rise in profit

May 24 Medtronic Plc reported a 25.5 percent rise in quarterly profit on Thursday on higher demand for its heart devices.

BRIEF-Mike Weinstein To Join Medtronic As Senior Vice President Of Strategy

* MIKE WEINSTEIN TO JOIN MEDTRONIC AS SENIOR VICE PRESIDENT OF STRATEGY Source text for Eikon: Further company coverage:

BRIEF-UK's CMA says Revoked Initial Enforcement Order On Completed Acquisition By Medtronic Of Animas Corp Assets

* UK'S CMA - HAS REVOKED INITIAL ENFORCEMENT ORDER MADE ON FEB 19 IN RELATION TO COMPLETED ACQUISITION BY MEDTRONIC PLC OF CERTAIN ASSETS OF ANIMAS CORP Source text (http://bit.ly/2jqGZ9X) Further company coverage:

BRIEF-Medtronic Announces New Paid Family Care Leave Benefits

* MEDTRONIC - EXPANDED PAID FAMILY LEAVE BENEFITS; ALL FULL-TIME, PART-TIME U.S. EMPLOYEES TO BE COVERED UNDER MEDTRONIC FAMILY CARE LEAVE POLICY Source text for Eikon: Further company coverage:

BRIEF-Medtronic Receives FDA Approval For Deep Brain Stimulation Therapy For Type Of Epilepsy

* MEDTRONIC RECEIVES FDA APPROVAL FOR DEEP BRAIN STIMULATION THERAPY FOR MEDICALLY REFRACTORY EPILEPSY

BRIEF-Medtronic Announces FDA Approval Of Infuse Bone Graft In New Spine Surgery Indications

* MEDTRONIC ANNOUNCES FDA APPROVAL OF INFUSE(TM) BONE GRAFT IN NEW SPINE SURGERY INDICATIONS USING PEEK INTERBODY IMPLANTS Source text for Eikon: Further company coverage:

Edward Lifesciences' heart valve sales in Europe disappoint, shares fall

Edwards Lifesciences Corp's first-quarter sales for transcatheter heart valves missed Wall Street targets on Tuesday, as the medical device maker lost market share in Europe to its rival, Medtronic Plc .

Select another date: